科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/11 | 4,910 | 5,010 | 4,905 | 4,950 | +40 | +0.8% | 144,300 |
2020/08/07 | 4,840 | 4,945 | 4,840 | 4,910 | +60 | +1.2% | 164,400 |
2020/08/06 | 4,880 | 4,910 | 4,810 | 4,850 | -125 | -2.5% | 218,400 |
2020/08/05 | 4,930 | 5,020 | 4,930 | 4,975 | +10 | +0.2% | 167,900 |
2020/08/04 | 4,975 | 5,080 | 4,900 | 4,965 | +95 | +2% | 211,800 |
2020/08/03 | 4,880 | 4,935 | 4,825 | 4,870 | +95 | +2% | 179,300 |
2020/07/31 | 4,910 | 4,940 | 4,750 | 4,775 | -180 | -3.6% | 286,800 |
2020/07/30 | 4,945 | 4,985 | 4,930 | 4,955 | +10 | +0.2% | 82,800 |
2020/07/29 | 4,950 | 4,975 | 4,910 | 4,945 | -50 | -1% | 152,600 |
2020/07/28 | 5,040 | 5,110 | 4,995 | 4,995 | +10 | +0.2% | 134,900 |
2020/07/27 | 4,995 | 5,050 | 4,950 | 4,985 | -65 | -1.3% | 165,700 |
2020/07/22 | 5,000 | 5,100 | 5,000 | 5,050 | +40 | +0.8% | 141,300 |
2020/07/21 | 4,940 | 5,030 | 4,930 | 5,010 | -30 | -0.6% | 234,900 |
2020/07/20 | 5,060 | 5,110 | 5,030 | 5,040 | -20 | -0.4% | 119,700 |
2020/07/17 | 5,000 | 5,120 | 4,995 | 5,060 | +10 | +0.2% | 115,100 |
2020/07/16 | 5,090 | 5,100 | 5,030 | 5,050 | -140 | -2.7% | 183,800 |
2020/07/15 | 5,160 | 5,230 | 5,120 | 5,190 | +30 | +0.6% | 151,900 |
2020/07/14 | 5,180 | 5,260 | 5,140 | 5,160 | -80 | -1.5% | 130,900 |
2020/07/13 | 5,130 | 5,260 | 5,120 | 5,240 | +120 | +2.3% | 117,400 |
2020/07/10 | 5,170 | 5,210 | 5,120 | 5,120 | -10 | -0.2% | 113,500 |
2020/07/09 | 5,200 | 5,210 | 5,080 | 5,130 | -70 | -1.3% | 164,200 |
2020/07/08 | 5,330 | 5,390 | 5,200 | 5,200 | -120 | -2.3% | 166,400 |
2020/07/07 | 5,310 | 5,360 | 5,170 | 5,320 | -10 | -0.2% | 186,200 |
2020/07/06 | 5,270 | 5,380 | 5,270 | 5,330 | +90 | +1.7% | 96,400 |
2020/07/03 | 5,220 | 5,270 | 5,170 | 5,240 | +10 | +0.2% | 98,300 |
2020/07/02 | 5,240 | 5,290 | 5,180 | 5,230 | -60 | -1.1% | 226,000 |
2020/07/01 | 5,500 | 5,540 | 5,280 | 5,290 | -220 | -4% | 167,800 |
2020/06/30 | 5,550 | 5,600 | 5,510 | 5,510 | -20 | -0.4% | 150,600 |
2020/06/29 | 5,540 | 5,580 | 5,500 | 5,530 | -60 | -1.1% | 163,900 |
2020/06/26 | 5,520 | 5,610 | 5,520 | 5,590 | +70 | +1.3% | 96,100 |
2020/06/25 | 5,480 | 5,550 | 5,450 | 5,520 | -30 | -0.5% | 184,900 |
2020/06/24 | 5,610 | 5,660 | 5,510 | 5,550 | -160 | -2.8% | 232,600 |
2020/06/23 | 5,680 | 5,720 | 5,590 | 5,710 | +40 | +0.7% | 104,500 |
2020/06/22 | 5,650 | 5,720 | 5,640 | 5,670 | +20 | +0.4% | 84,500 |
2020/06/19 | 5,660 | 5,680 | 5,570 | 5,650 | -10 | -0.2% | 146,800 |
2020/06/18 | 5,630 | 5,690 | 5,600 | 5,660 | +70 | +1.3% | 103,200 |
2020/06/17 | 5,630 | 5,650 | 5,570 | 5,590 | -40 | -0.7% | 156,700 |
2020/06/16 | 5,650 | 5,670 | 5,570 | 5,630 | +140 | +2.6% | 197,700 |
2020/06/15 | 5,520 | 5,640 | 5,490 | 5,490 | -80 | -1.4% | 188,900 |
2020/06/12 | 5,550 | 5,580 | 5,470 | 5,570 | -40 | -0.7% | 264,100 |
2020/06/11 | 5,700 | 5,700 | 5,590 | 5,610 | -120 | -2.1% | 150,500 |
2020/06/10 | 5,680 | 5,740 | 5,640 | 5,730 | +70 | +1.2% | 213,800 |
2020/06/09 | 5,710 | 5,730 | 5,610 | 5,660 | -110 | -1.9% | 180,100 |
2020/06/08 | 5,770 | 5,780 | 5,720 | 5,770 | -70 | -1.2% | 180,800 |
2020/06/05 | 5,810 | 5,860 | 5,760 | 5,840 | -40 | -0.7% | 202,100 |
2020/06/04 | 5,860 | 5,990 | 5,810 | 5,880 | +70 | +1.2% | 277,900 |
2020/06/03 | 5,850 | 5,890 | 5,790 | 5,810 | +30 | +0.5% | 191,000 |
2020/06/02 | 5,780 | 5,790 | 5,730 | 5,780 | -40 | -0.7% | 181,200 |
2020/06/01 | 5,900 | 5,920 | 5,800 | 5,820 | -100 | -1.7% | 133,800 |
2020/05/29 | 5,800 | 5,950 | 5,780 | 5,920 | +160 | +2.8% | 316,900 |
1151~
1200
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 414,000円 | +30.5% | +111.0% | 4.59% | 11.67倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
住友ファーマ | 61,900円 | +21.1% | - | 0.00% | 15.37倍 | 2.15倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 187,700円 | +5.0% | +1.5% | 0.00% | 16.11倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 383,500円 | +14.5% | -2.3% | 2.35% | 14.03倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 228,200円 | - | - | 0.00% | - | 105.70倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム